Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-27 Purchase |
2025-01-29 4:24 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
124,500 | $0.7975 | $99,289 | 265,720 (Indirect Direct) |
View |
| 2024-02-07 Purchase |
2024-02-08 4:30 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
21,000 | $2.4536 | $51,526 | 139,702 (Indirect Direct) |
View |
| 2024-02-06 Purchase |
2024-02-07 4:22 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
20,000 | $2.5252 | $50,504 | 118,702 (Indirect Direct) |
View |
| 2023-06-12 Purchase |
2023-06-12 4:31 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
40,000 | $0.8 | $32,000 | 1,676,691 (Indirect Direct) |
View |
| 2023-04-14 Purchase |
2023-04-14 6:16 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
20,000 | $0.5499 | $10,998 | 1,636,691 (Indirect Direct) |
View |
| 2023-04-11 Purchase |
2023-04-13 4:51 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
60,000 | $0.48333 | $29,000 | 1,616,691 (Indirect Direct) |
View |
| 2021-06-23 Purchase |
2021-06-23 5:12 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
10,000 | $7.6716 | $76,716 | 1,638,235 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Tax Withholding |
2025-04-11 5:16 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
5,345 | $0.412 | 277,647 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-11 5:16 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
17,272 | $0 | 277,647 (Direct) |
View |
| 2025-01-29 Option Award(A) |
2025-02-18 5:57 pm |
2025-01-29 2030-01-29 |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
186,750 | $0 | 452,470 (Direct) |
View |
| 2024-06-28 Option Award |
2024-08-02 5:09 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
6,466 | $0 | 237,395 (Direct) |
View |
| 2024-04-05 Tax Withholding |
2024-08-02 5:09 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
518 | $2.79 | 237,395 (Direct) |
View |
| 2024-07-10 Tax Withholding |
2024-08-02 5:09 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
282 | $1.71 | 237,395 (Direct) |
View |
| 2024-04-05 Exercise |
2024-08-02 5:09 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
2,319 | $0 | 237,395 (Direct) |
View |
| 2024-01-01 Tax Withholding |
2024-04-12 5:01 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
518 | $2.79 | 160,192 (Direct) |
View |
| 2024-01-01 Exercise |
2024-04-12 5:01 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development |
1,675 | $0 | 160,192 (Direct) |
View |
| 2023-10-12 Option Award |
2023-10-12 5:54 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development 10% Owner |
155,277 | $0.29 | 1,973,968 (Direct) |
View |
| 2023-10-10 Option Award |
2023-10-10 5:03 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development 10% Owner |
142,000 | $0.24 | 1,818,691 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-10 5:04 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
18,750 | $0.8 | 1,556,691 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-04 5:39 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
49,380 | $0 | 824,716 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-03 4:48 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
25,350 | $0 | 374,993 (Direct) |
View |
| 2022-08-16 Gift |
2022-08-23 4:30 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
9,250 | $0 | 1,683,447 (Direct) |
View |
| 2022-08-05 Tax Withholding |
2022-08-09 4:26 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
2,531 | $3.17 | 1,692,697 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:26 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
7,601 | $0 | 1,692,697 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:33 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
46,877 | $0 | 349,643 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-11 6:00 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
247,841 | $0 | 302,766 (Direct) |
View |
| 2021-11-01 Option Award |
2022-04-04 5:45 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
15,001 | $0 | 64,847 (Direct) |
View |
| 2021-12-31 Option Award(A) |
2022-01-06 5:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
6,722 | $0 | 22,780 (Direct) |
View |
| 2021-09-30 Option Award(A) |
2022-01-06 3:57 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
6,024 | $0 | 16,058 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 5:34 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
6,722 | $0 | 6,722 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 4:36 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
6,024 | $0 | 6,024 (Direct) |
View |
| 2021-08-05 Option Award |
2021-08-09 4:33 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
7,601 | $0 | 1,687,627 (Direct) |
View |
| 2021-07-08 Option Award |
2021-07-09 4:33 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
23,337 | $0 | 31,464 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:04 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
8,127 | $0 | 8,127 (Direct) |
View |
Ownership(A) |
2020-10-05 09:15 am |
2018-06-29 2021-06-29 |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer |
0 | $0 | 53,921 (Direct) |
View |
Ownership |
2020-10-02 4:52 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer |
0 | $0 | 1,698,679 (Direct) |
View |